| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in ARWR over the last quarter tilts toward selling: insiders offloaded a net 13,600 shares worth roughly $1.2M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.79M | $225.78M | - | |
| COO | 547.4K | $32.59M | - | |
| Other | 227.0K | $13.51M | - | |
| CFO | 162.9K | $9.70M | - | |
| Dir | 111.5K | $6.64M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 19, 2019 | Kenneth Allen Myszkowski68 | Chief Financial Officer | Sale+OE | 8,000 | $18.00 | $144,000.00 | -2.6% | |
| Feb 19, 2019 | Bruce D Given | Chief Operating Officer | Sale+OE | 68,750 | $17.86 | $1,227,987.50 | -9.6% | |
| Feb 12, 2019 | Bruce D Given | Chief Operating Officer | Sale+OE | 242,834 | $16.04 | $3,894,247.00 | -26.6% | |
| Feb 5, 2019 | Bruce D Given | Chief Operating Officer | Sell | 22,500 | $14.48 | $325,800.00 | -2.6% | |
| Feb 1, 2019 | Bruce D Given | Chief Operating Officer | Sell | 28,500 | $13.85 | $394,725.00 | -3.2% | |
| Jan 23, 2019 | Bruce D Given | Chief Operating Officer | Sell | 169,500 | $13.54 | $2,295,805.00 | -15.9% | |
| Jan 22, 2019 | Douglas B Given66 | Director | Sell | 3,000 | $13.58 | $40,740.00 | -1.7% | |
| Jan 18, 2019 | Patrick O'Brien76 | General Counsel | Sell | 72,000 | $14.43 | $1,038,960.00 | -23.6% | |
| Jan 17, 2019 | Kenneth Allen Myszkowski68 | Chief Financial Officer | Sell | 81,875 | $14.55 | $1,191,281.25 | -21.1% | |
| Jan 14, 2019 | Zhen Li | Snr. VP, Chem and Non-clin Dev | Sell | 40,500 | $14.34 | $580,770.00 | -16.7% |